
News|Articles|June 1, 2011
Formulary Digital Edition June 2011
Multiple sclerosis: A paradigm change with oral agents?; Focus On Telaprevir: A novel, protease inhibitor for the treatment of hepatitis C virus
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
PBM reform. It has finally happened
3
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
4
TrumpRx launches; some experts question its long-term value
5

























